GL1X · GenesisL1 explorer

Research workbench

A novel anti-tumor cytokine contains a RNA-binding motif present in aminoacyl-tRNA synthetases

Analyse A novel anti-tumor cytokine contains a RNA-binding motif present in… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1EUJ
Type
protein
Length
328 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Endothelial monocyte activating polypeptide 2
UniProt
Q12904
Pockets
3 · best druggability 0.47

Structure

x-ray diffraction · 1 distinct chain · 10% helix, 41% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BEndothelial monocyte activating polypeptide 2protein16410% helix, 41% strandQ12904

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11560.470.7729empty
2620.390.7912empty
3850.380.7616empty

Interfaces

1 interface between chains.

  • A–B · 582 Ų buried · 11 hydrogen bonds · protein-protein

Compared structures

  • 1EUJ · A novel anti-tumor cytokine contains a RNA-binding motif present in aminoacyl-tRNA… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q12904 · AlphaFold monomer V2.0 prediction for aminoacyl tRNA synthase complex-interacting… · a predicted model of the same protein · chain B against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.